He aha kāu e ʻike ai e pili ana i ka palmitoylethanolamide (PEA)?

ʻO Palmitoylethanolamide (PEA) kahi amide momona momona maoli i hoʻokipa i ka nānā ʻana no kāna mau pono olakino. Loaʻa kēia pūhui i loko o nā ʻiʻo like ʻole a puni ke kino, a ʻo ka noiʻi e hōʻike ana e hiki i ka palmitamideethanol (PEA) ke hoʻēmi i ka mumū, hoʻemi i ka ʻeha, a hiki ke hoʻoikaika i ke olakino ʻōpū a hoʻopaneʻe i ka ʻelemakule. Loaʻa paha iā ia nā ʻano pono olakino. E ʻimi ka ʻike ma lalo nei i nā pono olakino o ka palmitoylethanolamide (PEA), pehea e hana ai i ke kino o ke kanaka, a pehea e ʻike ai i ka palmitoylethanolamide (PEA) kiʻekiʻe.

He aha ka palmitoylethanolamide (PEA)?

Palmitoylethanolamide (PEA) ʻO kahi pūhui endocannabinoid-like kūlohelohe i ʻike ʻia no kāna mau analgesic mau a me nā waiwai anti-inflammatory. Ma waho aʻe o ka synthesized e ke kino, loaʻa ka PEA i nā ʻano meaʻai like ʻole: cheese, egg yolks, ʻiʻo, waiū, pīkī, soy lecithin.

ua ʻike anei ʻoe? Ke hālāwai ke kino i nā mea koʻikoʻi, e like me ka ʻeha a i ʻole ka mumū, hoʻololi nā pae PEA e mālama i ka homeostasis cellular.

Pehea ka hopena o ka palmitoylethanolamide i ke kino o ke kanaka?

ʻAʻole maopopo ka poʻe ʻepekema i ke ʻano o ka hana o ka palmitoylethanolamide. Eia nō naʻe, ua hele mākou i kahi ala lōʻihi, mahalo iā Professor Rita Levi-Montalcini, nāna i wehewehe i ka 1992-1996 i ke ʻano o ka hana o ka palmitoylethanolamide. Mai ia manawa, ua hoʻomau ʻo ia e aʻo i nā hopena o ka palmitoylethanolamide ma ka ʻeha neuropathic a me nā allergies.

Hiki i ka Palmitoylethanolamide ke lawe mai i ʻehā mau pono olakino nui i ke kanaka:

●Hoʻokuʻu i ka pane inflammatory.

● Hoʻemi i ka hoʻoulu ʻana o ka mast cell (allergy).

●E hoʻoikaika i ka hana o ka ʻōnaehana hemp endogenous.

●E ho'ā i nā mea loaʻa kikoʻī i loko o ke kino.

Pehea e hoʻohana ai ka PEA i kāna mau hopena anti-inflammatory a me analgesic?

ʻO nā pono olakino o ka PEA e pili ana i nā hopena i nā cell immune e hoʻomalu i ka mumū, ʻoi loa i ka lolo. Hiki i ka PEA ke kōkua i ka hoʻemi ʻana i ka hana ʻana o nā mea ʻona. Eia nō naʻe, hana nui ka PEA i nā mea loaʻa i nā cell, nāna e mālama i nā ʻano like ʻole o ka hana cell. Kapa ʻia kēia mau mea loaʻa he PPAR. Hiki i ka PEA a me nā pūhui ʻē aʻe ke hoʻoikaika i ka PPAR ke hōʻemi i ka ʻeha a hiki ke hoʻonui i ka metabolism ma o ka puhi ʻana i ka momona, hoʻohaʻahaʻa i ka triglycerides serum, hoʻonui i ka cholesterol HDL serum, hoʻomaikaʻi i ka mālama ʻana i ke kō koko, a kōkua i ka pohō kaumaha.

Nā Pōmaikaʻi Palmitoylethanolamide

Ma muli o kāna mau analgesic a me nā hopena anti-inflammatory, hōʻike ka noiʻi e hiki i ka PEA ke kōkua i nā ʻano maʻi e pili ana i ka ʻeha, e like me ka fibromyalgia, sciatica, a me ka osteoarthritis.

1. Hoʻopau i ka ʻeha a me ka pane inflammatory

He pilikia koʻikoʻi ka ʻeha maʻi e hōʻeha nei i nā poʻe maʻi a puni ka honua, a i ka wā o ka nui o ka heluna kanaka, e lilo kēia pilikia i mea nui. ʻO kekahi o nā hana o ka palmitoylethanolamide ʻo ia ke kōkua i ka hoʻomaha ʻana i ka ʻeha a me ka ʻeha. Hoʻopili ka palmitoylethanolamide me CB1 a me CB2 mau mea hoʻokipa, he mau mea nui ia o ka ʻōnaehana hemp endogenous. ʻO kēia ʻōnaehana ke kuleana no ka mālama ʻana i ka homeostasis a i ʻole ke kaulike ma ke kino.

Ke loaʻa kahi hōʻeha a i ʻole ka pane ʻeha, hoʻokuʻu ke kino i nā pūhui hemp endogenous e kōkua i ka hoʻomalu ʻana i ka pane immune. Hiki i ka palmitoylethanolamide ke kōkua i ka hoʻonui ʻana i nā pae hemp endogenous i loko o ke kino, a laila e hoʻomaha ai i ka ʻeha a me ka mumū.

Eia hou, hiki i ka palmitoylethanolamide ke hōʻemi i ka hoʻokuʻu ʻana o nā kemika inflammatory a hōʻemi i nā pane ʻeha neurological holoʻokoʻa. Hoʻolilo kēia mau hopena i ka palmitoylethanolamide i mea pono e kōkua i ka hoʻomalu ʻana i ka ʻeha a me nā pane ʻeha. Hōʻike nā haʻawina e hiki ke hana maikaʻi ka palmitoylethanolamide no ka ʻeha sciatica a me ka maʻi carpal tunnel.

2. Fibromyalgia

Manaʻo kekahi mau haʻawina e hiki i ka PEA ke kōkua i ka hōʻemi ʻana i nā hōʻailona o ka fibromyalgia, kahi maʻi neurological mau loa e hoʻonui ai i ka ʻeha. Ke hoʻohana ʻia ma ke ʻano he mea hoʻohui i nā lāʻau lapaʻau kuʻuna, hoʻemi ʻo PEA ingestion i ka ʻeha nui a hoʻomaikaʻi i ka maikaʻi o ke ola i ka manawa. Wahi a kekahi noiʻi, ʻo ka lawe ʻana i ka PEA no ʻekolu mahina i hoʻemi nui i ka ʻeha i nā poʻe me ka fibromyalgia.

3. ʻEha hope

Hōʻike ka noiʻi mua i ka pono o ka PEA no ka ʻeha hope. Ua hōʻike ʻia kahi haʻawina hoʻomaʻamaʻa 2017 e hoʻemi hou ka PEA i ka nui o ka ʻeha i nā poʻe maʻi me ka maʻi hōʻeha hope hope.

ʻO ka poʻe i loaʻa i ka sciatica, kahi ʻeha e hōʻea ana mai ke kua haʻahaʻa i lalo i hoʻokahi a i ʻole nā ​​wāwae ʻelua, hiki ke loaʻa ka hōʻoluʻolu ma hope o ka lawe ʻana i ka PEA. Ua aʻo ʻia kahi hoʻokolohua hoʻāʻo ʻia, pālua-makapō, placebo-controlled i nā hopena o ka PEA kiʻekiʻe a me ka haʻahaʻa me ka placebo. Ua ho'ēmiʻia kaʻeha ma mua o 50% i ka hui kiʻekiʻe. ʻOiai ʻaʻole i loaʻa i ka PEA haʻahaʻa haʻahaʻa i ka pae like o ka hōʻoluʻolu ʻeha e like me ke kiʻekiʻe, ua ʻoi aku ka maikaʻi o nā kau ʻelua ma mua o ka placebo.

4. Osteoarthritis

Hiki i ka PEA ke kōkua i ka poʻe me ka osteoarthritis, kahi maʻi i hōʻike ʻia e ka degeneration o ka cartilage hui a me ka iwi. ʻO ka poʻe i komo i hoʻokahi haʻawina i loaʻa iā PEA ua loaʻa i nā hoʻomaikaʻi koʻikoʻi ma Western Ontario a me McMaster Universities Osteoarthritis Index (WOMAC) i hoʻohālikelike ʻia me ka hui placebo. He nīnau nīnau ka WOMAC no ka nānā ʻana i ke kūlana a me nā hōʻailona (e laʻa, ʻeha, ʻoʻoleʻa, hana kino) i nā poʻe maʻi me ka osteoarthritis kuli a me ka ʻūhā.

ʻO kekahi haʻawina e pili ana i nā poʻe maʻi me ka ʻeha temporomandibular arthritic (TMJ) e pili ana me ka osteoarthritis i hōʻike ʻia ua hoʻomaikaʻi nui ka PEA supplementation i ka ʻeha ma hope o 14 mau lā i hoʻohālikelike ʻia me ka ibuprofen. ʻO ka hui i hāʻawi ʻia iā PEA no nā lā 14 i hōʻike i ka hoʻomaikaʻi nui ʻana i ka wehe ʻana o ka waha (he ana o ka ʻeha ʻeha) ma mua o ka hui ibuprofen.

5. ʻeha neuropathic

ʻO nā haʻawina mua a me nā hoʻāʻo holoholona e hōʻike ana hiki i ka PEA ke kōkua i ka ʻeha neuropathic (ma muli o ka hōʻino ʻana i nā aʻalolo e lawe ana i nā leka ma waena o ka lolo a me ke kuamoʻo), ʻoi aku ka nui o nā poʻe me ka carpal tunnel syndrome, neuropathy diabetic, chemotherapy ʻO nā kānaka me ke neuropathy peripheral, maʻi maʻi. ʻeha pelvic, a me ka ʻeha e pili ana i ka hahau a me ka maʻi sclerosis lehulehu. Pono nā hoʻokolohua lapaʻau hou e hoʻoholo i ka pono o ka PEA i ka hoʻonā ʻana i ka ʻeha neuropathic.

6. Ola Ola

ʻO ka hoʻopaneʻe ʻana i ke kaʻina hana ʻelemakule kahi pahuhopu o ka waiwai kūpono i ʻimi ʻia e nā ʻepekema he nui a puni ka honua. Manaʻo ʻia ʻo Palmitoylethanolamide he mea hoʻohui anti-aging e hiki ke kōkua i ka pale ʻana i nā cell mai ka pōʻino oxidative, ʻo ia ke kumu nui o ka ʻelemakule.

Ke ʻike ʻia nā cell i ka hana radical manuahi nui loa, hiki i nā hopena oxidative ke hiki mai, e alakaʻi ana i ka make cell premature. ʻO ka lawe ʻana i nā meaʻai maikaʻi ʻole, ka puhi ʻana, a me nā mea ʻē aʻe e pili ana i ke kaiapuni e like me ka haumia o ka ea e hoʻonui i ka pōʻino oxidative. Hiki i ka Palmitoylethanolamide ke pale i kēia pōʻino ma ka wehe ʻana i nā radical manuahi a hoʻemi i ka pane ʻana o ke kino holoʻokoʻa.

Hoʻohui ʻia, ua hōʻike ʻia ka palmitoylethanolamide ethanol e hiki ke hoʻoulu i ka hana ʻana o ka collagen a me nā protein ʻili pono ʻē aʻe. No laila, hiki ke hōʻemi i ke ʻano o nā wrinkles a me nā laina maikaʻi, e hana ana ma ke ʻano he pale mai loko mai o nā keʻena.

ʻO Suzhou Myland Pharm & Nutrition Inc. he mea hana i kākau inoa ʻia e FDA e hāʻawi ana i ka pauka Palmitoylethanolamide (PEA) kiʻekiʻe a maikaʻi.

Ma Suzhou Myland Pharm mākou e hoʻolako i nā huahana kiʻekiʻe loa i nā kumukūʻai maikaʻi loa. ʻO kā mākou Palmitoylethanolamide (PEA) pauka i ho'āʻo ikaikaʻia no ka maʻemaʻe a me ka ikaika, e hōʻoiaʻiʻo ana e loaʻa iāʻoe kahi mea hoʻonui kiʻekiʻe āu e hilinaʻi ai. Inā makemake ʻoe e kākoʻo i ke olakino cellular, hoʻonui i kāu ʻōnaehana pale, a hoʻomaikaʻi paha i ke olakino holoʻokoʻa, ʻo kā mākou Palmitoylethanolamide (PEA) pauka ke koho maikaʻi loa.

Me 30 mau makahiki o ka ʻike a alakaʻi ʻia e ka ʻenehana kiʻekiʻe a me nā hoʻolālā R&D maikaʻi loa, ua hoʻomohala ʻo Suzhou Myland Pharm i nā ʻano huahana hoʻokūkū a lilo i mea hoʻohui ʻepekema ola hou, synthesis maʻamau a me nā ʻoihana lawelawe hana.

Eia kekahi, ʻo Suzhou Myland Pharm kekahi mea hana inoa FDA. ʻO nā kumuwaiwai R&D o ka hui, nā lako hana, a me nā mea hana analytical he mea hou a he nui nā hana, a hiki ke hana i nā kemika mai ka milligrams a hiki i nā tona ma ka pālākiō, a hoʻokō i nā kūlana ISO 9001 a me nā kikoʻī hana GMP.